Ratings TerrAscend Corp.

Equities

TSND

CA88105E1088

Delayed Toronto S.E. Other stock markets 19:24:03 30/04/2024 BST			5-day change	1st Jan Change
2.81 ^CAD	+18.07%		+24.45%	+29.55%

04-24	Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New Jersey	CI
03-14	Transcript : TerrAscend Corp., 2023 Earnings Call, Mar 14, 2024

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past four months, analysts' average price target has been revised upwards significantly.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

The company sustains low margins.
The company is in debt and has limited leeway for investment
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Drug Retailers

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TERRASCEND CORP.	+29.55%	508M		-
GREEN THUMB INDUSTRIES INC.	+39.54%	2.88B		D+
VERANO HOLDINGS CORP.	+15.65%	1.71B		-
GLASS HOUSE BRANDS INC.	+111.63%	626M		-
HIGH TIDE INC.	+45.54%	158M		-
CANTOURAGE GROUP SE	+8.64%	105M	-	-
NOVA CANNABIS INC.	+58.43%	57.54M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes